118 related articles for article (PubMed ID: 38590234)
1. Prognostic effect of TCF1+ CD8+ T cell and TOX+ CD8+ T cell infiltration in lung adenocarcinoma.
Wang Y; Ma L; Chen Y; Yun W; Yu J; Meng X
Cancer Sci; 2024 Apr; ():. PubMed ID: 38590234
[TBL] [Abstract][Full Text] [Related]
2. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of TCF1+CD8+T in primary small cell carcinoma of the esophagus.
Ma L; Sun L; Zhao K; Dong Z; Huang Z; Meng X
Cancer Sci; 2021 Dec; 112(12):4968-4976. PubMed ID: 34657342
[TBL] [Abstract][Full Text] [Related]
4. Tumor immunogenicity dictates reliance on TCF1 in CD8
Escobar G; Tooley K; Oliveras JP; Huang L; Cheng H; Bookstaver ML; Edwards C; Froimchuk E; Xue C; Mangani D; Krishnan RK; Hazel N; Rutigliani C; Jewell CM; Biasco L; Anderson AC
Cancer Cell; 2023 Sep; 41(9):1662-1679.e7. PubMed ID: 37625402
[TBL] [Abstract][Full Text] [Related]
5. CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.
Koyama-Nasu R; Kimura MY; Kiuchi M; Aoki A; Wang Y; Mita Y; Hasegawa I; Endo Y; Onodera A; Hirahara K; Motohashi S; Nakayama T
Cancer Immunol Res; 2023 Aug; 11(8):1085-1099. PubMed ID: 37216576
[TBL] [Abstract][Full Text] [Related]
6. Characterization of TCF-1 and its relationship between CD8+ TIL densities and immune checkpoints and their joint influences on prognoses of lung adenocarcinoma patients.
Jiang K; Liu S; Chen Y; Xu Z; Xu Z; Qian B; Ding Q; Cui H; Sui Y; Cao D; Xu W; Shen M
Thorac Cancer; 2023 Sep; 14(27):2745-2753. PubMed ID: 37536668
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive profile of TCF1
Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z
Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between Immune Microenvironment Features and EGFR Mutation Status
in Lung Adenocarcinoma].
Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
[TBL] [Abstract][Full Text] [Related]
10. The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness.
Wu T; Ji Y; Moseman EA; Xu HC; Manglani M; Kirby M; Anderson SM; Handon R; Kenyon E; Elkahloun A; Wu W; Lang PA; Gattinoni L; McGavern DB; Schwartzberg PL
Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28018990
[TBL] [Abstract][Full Text] [Related]
11. Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma.
Du M; Liang Y; Liu Z; Li X; Liang M; Zhou B; Gao Y
Front Oncol; 2021; 11():693353. PubMed ID: 34650911
[TBL] [Abstract][Full Text] [Related]
12. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
14. CD8
Prokhnevska N; Cardenas MA; Valanparambil RM; Sobierajska E; Barwick BG; Jansen C; Reyes Moon A; Gregorova P; delBalzo L; Greenwald R; Bilen MA; Alemozaffar M; Joshi S; Cimmino C; Larsen C; Master V; Sanda M; Kissick H
Immunity; 2023 Jan; 56(1):107-124.e5. PubMed ID: 36580918
[TBL] [Abstract][Full Text] [Related]
15. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
Front Immunol; 2022; 13():985280. PubMed ID: 36211334
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor immune microenvironment factors in patients with stage I lung adenocarcinoma.
Xue Q; Wang Y; Zheng Q; Chen L; Lin Y; Jin Y; Shen X; Li Y
Am J Cancer Res; 2023; 13(3):950-963. PubMed ID: 37034213
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
Xiao G; Li L; Tanzhu G; Liu Z; Gao X; Wan X; Xiao D; Chen L; Xia X; Zhou R
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868569
[TBL] [Abstract][Full Text] [Related]
18. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
[TBL] [Abstract][Full Text] [Related]
19. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma.
Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X
Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299
[TBL] [Abstract][Full Text] [Related]
20. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]